Division of Cardiology, Department of Internal Medicine, Palmetto General Hospital, 2001 W 68th St, Hialeah, FL, 33016, USA.
Heart and Vascular Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Cardiovasc Interv Ther. 2022 Jan;37(1):167-181. doi: 10.1007/s12928-020-00753-4. Epub 2021 Jan 16.
Coronary artery disease (CAD) and severe aortic valve stenosis frequently coexist. Given the progressive nature of CAD, silent or non-significant CAD may become symptomatic or functionally relevant years after TAVR. However, there is a paucity of data documenting the feasibility of either coronary angiography and/or PCI after TAVR. We systematically searched Medline, Pubmed, Embase, Cochrane database, Google Scholar, Science Direct, Web of Science, and conference abstracts from conception to March 2020 using OvidSP in TAVR patients undergoing coronary angiography with or without PCI at least 6 months after TAVR. Patients and procedural characteristics were summarized. The primary outcome of interest was successful coronary angiography for either the left main coronary artery (LMCA) or right coronary artery (RCA) with or without PCI. Pooled estimates were calculated using a random-effects meta-analysis. The study protocol was registered in PROSPERO. Eleven reports for a total of 696 coronary angiograms and 287 PCI were included in the analysis. Patients were slightly predominantly male, older and had a mean left ventricular ejection fraction of more than 50% with an intermediate STS. The summary estimate rates of successful LMCA and RCA angiography with a Medtronic self-expandable valve (SEV) were 84% (95% CI 73-90%, I = 79, p = 0.015) and 69% (95% CI 37-89%, I = 86, p = 0.23), respectively, while with the Edwards Lifesciences balloon expandable valve (BEV), the summary estimate rates for successful LMCA and RCA angiography were 94% (95% CI 72-99%, I = 66, p = 0.003) and 95% (95% CI 48-99%, I = 83, p = 0.05), respectively. The summary estimate rate of successful PCI post TAVR with either a Medtronic SEV or Edwards Lifesciences BEV was 93% (95% CI 86-96%, I = 33, p = 0.0001). The overall achievement of a successful coronary angiography with or without PCI in post-TAVR patients is high, with a lower success rate for RCA angiography in patients with the Medtronic SEV Mortality and bleeding did not differ in our analysis.
冠状动脉疾病 (CAD) 和严重的主动脉瓣狭窄常同时存在。鉴于 CAD 的进展性质,TAVR 多年后,无症状或非显著性 CAD 可能会出现症状或功能相关。然而,关于 TAVR 后进行冠状动脉造影和/或经皮冠状动脉介入治疗 (PCI) 的可行性数据很少。我们使用 OvidSP 在 TAVR 患者中系统地搜索了 Medline、Pubmed、Embase、Cochrane 数据库、Google Scholar、Science Direct、Web of Science 和会议摘要,从概念到 2020 年 3 月,至少在 TAVR 后 6 个月进行了冠状动脉造影和/或 PCI 的患者。总结了患者和程序特征。主要观察终点为左主干冠状动脉 (LMCA) 或右冠状动脉 (RCA) 成功进行冠状动脉造影,包括或不包括 PCI。使用随机效应荟萃分析计算汇总估计值。该研究方案已在 PROSPERO 中注册。分析共纳入了 11 项研究,共 696 例冠状动脉造影和 287 例 PCI。患者主要为男性,年龄较大,平均左心室射血分数超过 50%,STS 评分中等。使用美敦力自膨式瓣膜 (SEV) 的 LMCA 和 RCA 血管造影成功的汇总估计率分别为 84%(95%CI 73-90%,I=79,p=0.015)和 69%(95%CI 37-89%,I=86,p=0.23),而使用爱德华兹生命科学气球扩张瓣膜 (BEV) 的 LMCA 和 RCA 血管造影成功的汇总估计率分别为 94%(95%CI 72-99%,I=66,p=0.003)和 95%(95%CI 48-99%,I=83,p=0.05)。TAVR 后使用美敦力 SEV 或爱德华兹生命科学 BEV 进行 PCI 的汇总估计成功率为 93%(95%CI 86-96%,I=33,p=0.0001)。TAVR 后患者行冠状动脉造影和/或 PCI 的成功率总体较高,使用美敦力 SEV 的 RCA 血管造影成功率较低。在我们的分析中,死亡率和出血率没有差异。